$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
艾曲波帕治疗血小板减少症效果好吗?一般吃多久见效
2025-10-19 11:44:20
Check Details
阿伐曲泊帕在天津怎么购买?阿伐曲泊帕用法用量是怎样的?
2025-10-19 11:44:20
Check Details
服用阿伐曲泊帕需要注意什么?有什么副作用?
2025-10-19 11:44:20
Check Details
艾曲波帕(Revolade)会产生耐药吗?需要注意哪些
2025-10-19 11:44:20
Check Details
阿伐曲泊帕中国获批治疗慢性肝病患者(CLD)血小板减少症
2025-10-19 11:44:20
Check Details
慢性免疫性血小板减少症新药:阿伐曲泊帕片!
2025-10-19 11:44:20
Check Details
阿伐曲泊帕Avatrombopag可使88%的患者不需输注血小板
2025-10-19 11:44:20
Check Details
阿伐曲泊帕多少钱一盒?哪里有便宜的阿伐曲泊帕
2025-10-19 11:44:20
Check Details
今天康护乐小编就带大家了解一下艾曲波帕这个药物
2025-10-19 11:44:20
Check Details
艾曲波帕的使用方法是什么?副作用呢?
2025-10-19 11:44:20
Check Details
阿伐曲泊帕怎么服用?阿伐曲泊帕疗效怎么样?
2025-10-19 11:44:20
Check Details
首款口服药艾曲波帕上市开创了血小板减少症的新纪元
2025-10-19 11:44:20
Check Details
1
2
...
910
911
912
913
914
915
916
...
937
938
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Bosutinib Indications Explained: CML Targeted Therapy and ADPKD Research Insights
2
Revumenib Mechanism Explained: Targeting menin-KMT2A Interaction to Reshape Leukemia Cell Fate
3
Asciminib (Scemblix): Targeted Mechanism, Dosing Regimens, and Missed-Dose Guidance
4
Gilteritinib (XOSPATA): Dosing Cycle, Treatment Duration, and Development Background
5
Long-Term Anagrelide Use: Common Adverse Effects and Key Monitoring Considerations
6
Anagrelide vs. Hydroxyurea in Essential Thrombocythemia: Efficacy Profiles and Clinical Positioning
7
SCEMBLIX (Asciminib) Side Effect Management & Special Population Guide
8
Asciminib (SCEMBLIX): STAMP Inhibitor Dosing Guide and Nomenclature Clarification for CML
9
Enasidenib (IDHIFA): A Comprehensive Guide to Targeted Therapy for IDH2-Mutated Acute Myeloid Leukemia
10
Midostaurin vs. Gilteritinib: Key Differences in FLT3-Targeted AML Therapy
11
How Long Does Belumosudil Take to Work for Pulmonary cGVHD?
12
Tazemetostat: Mechanism, Standard Dosing, and the 2026 Global Withdrawal of the First-in-Class EZH2 Inhibitor